Vitamin K status and physical decline in older adults—The Longitudinal Aging Study Amsterdam by van Ballegooijen, Adriana J. et al.
VU Research Portal
Vitamin K status and physical decline in older adults—The Longitudinal Aging Study
Amsterdam





DOI (link to publisher)
10.1016/j.maturitas.2018.04.013
document version
Publisher's PDF, also known as Version of record
document license
Article 25fa Dutch Copyright Act
Link to publication in VU Research Portal
citation for published version (APA)
van Ballegooijen, A. J., van Putten, S. R., Visser, M., Beulens, J. W., & Hoogendijk, E. O. (2018). Vitamin K
status and physical decline in older adults—The Longitudinal Aging Study Amsterdam. Maturitas, 113, 73-79.
https://doi.org/10.1016/j.maturitas.2018.04.013
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Download date: 27. May. 2021
Contents lists available at ScienceDirect
Maturitas
journal homepage: www.elsevier.com/locate/maturitas
Vitamin K status and physical decline in older adults—The Longitudinal
Aging Study Amsterdam
Adriana J. van Ballegooijena,⁎, Sinony R. van Puttena, Marjolein Vissera, Joline W. Beulensb,c,
Emiel O. Hoogendijkc
a Department of Health Sciences, Amsterdam Public Health Institute, VU University, Amsterdam, The Netherlands
bDepartment of Epidemiology and Biostatistics, Amsterdam Public Health Institute, VU University Medical Center, Amsterdam, The Netherlands
c Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands






A B S T R A C T
Objective: We examined the association between vitamin K status and physical functioning over 13 years in the
Longitudinal Aging Study Amsterdam.
Study design: Longitudinal cohort study of 633 community-dwelling adults from the Longitudinal Aging Study
Amsterdam (LASA) aged 55–65 years (54% women).
Main outcome measures: At baseline (2002–2003), plasma desphospho-uncarboxylated matrix Gla protein (dp-
ucMGP) was measured with a sandwich ELISA as a marker of vitamin K status. The outcome measures handgrip
strength, calf circumference, self-reported functional limitations and functional performance were obtained at
baseline and four follow-up examinations. We used generalized estimating equations to determine the re-
lationship between dp-ucMGP tertiles and the various outcome measurements after adjusting for potential
confounders. The lowest dp-ucMGP tertile reflects a high vitamin K status and was the reference.
Results: Mean dp-ucMGP was 376 ± 233 pmol/L and mean follow-up was 11.1 years. Participants showed a
decline in the outcome measures over time. Compared with the lowest tertile, the highest dp-ucMGP tertile had:
lower handgrip strength, 1.1 kg (95% confidence interval (−2.1, −0.1; P-trend<0.001); smaller calf cir-
cumference, −0.5 cm (−0.9 −0.1; P-trend= 0.018); and, only among women, a 0.7-point poorer functional
performance score (−1.1, −0.3; P-interaction= 0.002). Dp-ucMGP was not related to self-reported functional
limitations. No interaction effects between time and dp-ucMGP were observed.
Conclusions: Low vitamin K status was associated with lower handgrip strength, smaller calf circumference, and,
in women only, with poorer functional performance score. A low vitamin K status was however not related to the
13-year decline in these measures.
1. Introduction
Recently, there has been wide interest in the function of the fat-
soluble vitamin K. Vitamin K1 is the primary source of vitamin K in our
diet. It is present in green leafy vegetables, algae and plant oils. Vitamin
K2 comes in lower quantities, but has a longer half-life and data suggest
a higher absorption and bioavailability than vitamin K1 [1]. It is present
in meat, eggs, fermented dairy products and in limited amounts it can
be formed by bacteria in the gut from vitamin K1 [2].
Besides its well-known role in blood coagulation, vitamin K also
plays an important role as cofactor in the carboxylation of vitamin-K
dependent proteins present in vascular and skeletal tissue [3]. Matrix
Gla (γ-carboxyglutamate) protein (MGP) is a vitamin K-dependent
protein in the vascular wall, which requires vitamin K for
posttranslational carboxylation and both carboxylation and phosphor-
ylation for full activation [4]. MGP inhibits vascular calcification by
binding to calcium [5,6]. This suggests that sufficient vitamin K is re-
quired for optimal vascular health. Vitamin K deficiency leads to higher
amounts of uncarboxylated (inactive) fragments of MGP, and can be
measured by plasma desphospho-uncarboxylated matrix Gla protein
(dp-ucMGP) concentrations [7].
Several cross-sectional studies observed that high dp-ucMGP con-
centrations, indicative for a low vitamin K status, were associated with
higher concentrations of inflammatory markers [8] renal function de-
cline [9] and coronary heart disease [10] and below-knee arterial cal-
cification [11]. A prospective study observed that low plasma vitamin
K1 was associated with a 1.6 (1.1–2.3) higher risk of incident knee
osteoarthritis after 2.5 years follow-up [12]. Another prospective study
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observed that both phylloquinone and dp-ucMGP were associated with
better functional performance scores and faster gait speed at baseline,
however, after 4–5 years, neither vitamin K measure was associated
with the change in these outcomes [13].
Vitamin K-dependent mechanisms are involved in calcium meta-
bolism, and as a consequence of vitamin K deficiency, high dp-ucMGP
concentrations attenuate vascular calcium deposition [14–17]. This
leads to multiple comorbidities associated with functional decline such
as cartilage degeneration and vascular calcification. Hence, these
findings suggest that vitamin K deficiency may impair neuromuscular
as well as vascular function, which may negatively influence physical
functioning. Further, vitamin K promotes vascular smooth muscle dif-
ferentiation and has beneficial effects on both the large and small ar-
teries, which may lead to a better perfusion of muscle tissue [18].
Most previous studies were cross-sectional and the relationship with
physical functioning is largely unknown [8–13]. Therefore, we ex-
amined the longitudinal association between plasma dp-ucMGP and
physical functioning over 13 years in the Longitudinal Aging Study
Amsterdam.
2. Subjects and methods
2.1. Design and participants
We used data from the Longitudinal Aging Study Amsterdam
(LASA). LASA is an ongoing population-based study in Dutch adults that
started in 1992 to determine predictors and consequences of aging. A
detailed description of the cohort sampling and data collection proce-
dures has been described elsewhere [19]. Briefly, men and women aged
55–85 years were recruited by LASA personnel using registers of 11
municipalities in 3 geographical areas (Amsterdam/Zwolle/Oss) in the
Netherlands. The sample was randomly selected from municipal re-
gistries in 1992, with an oversampling of the oldest old and older men.
The initial response rate was 60% (n=3805). At each examination, 2
interviews were conducted: a main interview and a medical interview
with clinical measurements about 4–6 weeks apart.
For this present study, we included participants from the second
cohort, which started in 2002–2003. This cohort consisted of 1002 men
and women (aged 55–65 years). Four follow-up measurements took
place in 2005/2006, 2008/2009, 2011/2012 and 2015/2016. We
Fig. 1. Flow diagram of LASA participants per physical functioning outcome for each follow-up measurement between 2002 and 2016.
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excluded 369 participants from our analysis: n= 254 no blood sample,
n= 52 no vitamin K measurement, and n=19 used vitamin K an-
tagonists. Further, we excluded participants with no follow-up mea-
surements for physical functioning n= 44.
The analytical sample for the current analysis contained 633 LASA
participants with at least 1 follow-up measurements. Excluded partici-
pants (n=369) had more often type 2 diabetes (10% vs. 6%), number
of chronic diseases (range 0.9 vs. 0.7), were more current smokers (40%
vs. 26%) and more excessive alcohol drinkers (15% vs. 10%)
P < 0.008. The study was approved by the Ethics Review Board of the
VU University Medical Center, and informed consent was obtained from
all respondents.
2.2. Vitamin K status
At baseline (2002–2003) LASA study personnel collected morning
blood samples during a medical interview in a non-fasted state and
samples were shipped to the VU University Medical Center before.
Blood samples were centrifuged and stored at −80° until analysis in
2010–2011 and shipped to the laboratory of VitaK, Maastricht to esti-
mate dp-ucMGP concentrations. Plasma dp-ucMGP was measured with
a sandwich (dual antibody) ELISA, with the capture antibody directed
against the non-phosphorylated MGP sequence 3–15 and the detecting
antibody directed against the uncarboxylated MGP sequence 35–49
(mAbucMGP; VitaK, Maastricht, the Netherlands). High dp-ucMGP
concentrations reflect a low vitamin K status. The reported intra- and
inter-assay variation for plasma dp-ucMGP were 5.6 and 9.9%, re-
spectively [7].
2.3. Physical functioning
Handgrip strength is measured with a hand-held dynamometer ad-
justed for hand size to the nearest 1 kg (Takei TKK 5401, Takei
Scientific Instruments, Tokyo, Japan). The measurements were per-
formed in duplicate for both hands and calculated as the mean of both
hands in kilogram. Handgrip strength is commonly used as an indicator
of muscle strength, and is positively related to lower-extremity strength
[20].
Calf circumference is used as an indicator of skeletal muscle mass,
and is associated with higher strength [21]. Trained interviewers
measured calf circumference to the nearest 1 mm on the left leg with
the participant standing straight, feet 20 cm apart, body weight equally
distributed on both feet, at the widest circumference of the calf.
Self-reported functional limitations was measured with a ques-
tionnaire adapted from the Organization for Economic Cooperation and
Table 1
Baseline characteristics of 643 LASA participants stratified by plasma dp-
ucMGP tertiles.







Age (years) 59.6 ± 2.9 59.7 ± 2.9 60.2 ± 3.0
Women 116(47%) 112(52%) 114(58%)
Education
Low 87 (40%) 99 (46%) 83 (42%)
Intermediate 81 (37%) 74 (34%) 76 (39%)




135 (84–222) 161 (93–231) 152 (100–226)
BMI (kg/m2) 26.3 ± 3.6 26.9 ± 3.8 28.7 ± 4.6
Smoking status
Never 125 (57%) 116 (54%) 116 (59%)
Former 35 (16%) 38 (17%) 39 (20%)
Current 60 (27%) 62 (29% 42 (21%)
Alcohol consumption
Non-drinker 3 (1%) 8 (4%) 4 (2%)
Light drinker 117 (53%) 98 (45%) 104 (53%)
Moderate drinker 78 (36%) 87 (40%) 70 (35%)
(Very) excessive
drinker
22 (10%) 23 (11%) 19 (10%)
Disease state
Hypertension 40 (18%) 45 (21%) 57 (29%)
Osteoarthritis 64 (29%) 66 (31%) 63 (32%)
Type 2 diabetes 11 (5%) 9 (4%) 17 (9%)
Number of chronic
diseases (0–7)
0.6 ± 0.8 0.6 ± 0.7 0.8 ± 0.9
Metabolic
SBP (mmHg) 137 ± 21.3 141 ± 21.2 142 ± 28.5
DBP (mmHg) 82.2 ± 11.0 83.7 ± 11.9 84.4 ± 15.6
25(OH)D (nmol/L) 57.5 ± 21.2 55.5 ± 19.2 59.1 ± 20.8
eGFR (ml/min/
1.73m2)
72.2 ± 10.9 71.3 ± 12.6 67.5 ± 11.8




35.8 ± 11.1 34.9 ± 11.6 34.3 ± 11.7
≥1 functional
limitation
30 (15%) 28 (15%) 35 (21%)
Physical performance
(0–12)
9.3 ± 2.0 9.1 ± 2.3 8.8 ± 2.3
Calf circumference
(cm)
37.1 ± 2.8 37.2 ± 2.9 37.9 ± 3.2
Note: Values are mean ± SD or median and interquartile range. Abbreviations:
dp-ucMGP: dephosphorylated uncarboxylated Matrix Gla protein, SBP: systolic
blood pressure, DBP: Diastolic blood pressure, eGFR: estimated glomerular
filtration rate.
Table 2
Longitudinal associations between baseline plasma dp-ucMGP tertiles with
handgrip strength, calf circumference, and self-reported functional limitations
over 13 years follow-up.
Model 1 Model 2
Dp-ucMGP tertiles (pmol/L) Handgrip strength (kg) N=633
Low 0.0 0.0
Medium −0.8 (−1.8, 0.2) −1.0 (−1.9, 0.0)
High −0.7 (−1.7, 0.3) −1.1 (−2.1, −0.1)
P-trend 0.141 0.022
P-time < 0.001 <0.001
Calf circumference (cm) N=633
Low 0.0 0.0
Medium 0.1 (−0.4, 0.6) −0.3 (−0.6, 0.1)
High 0.9 (0.3, 1.5) −0.5 (−0.9, −0.1)
P-trend 0.003 0.018
P-time 0.071 0.111
≥1 functional limitation N=540
Low 1.0 1.0
Medium 1.2 (0.8, 1.8) 1.0 (0.6, 1.6)
High 1.8 (1.2, 2.8) 1.3 (0.8, 2.2)
P-trend 0.005 0.230
P-time < 0.001 <0.001
Note: Values for handgrip strength and calf circumference are regression coef-
ficients with 95% confidence intervals analyzed with generalized estimating
equations. For ≥1 functional limitation values represent odds ratios with 95%
confidence intervals.
dp-ucMGP: dephosphorylated uncarboxylated matrix gla protein.
Model 1: adjusted for time (years) and age (years) and sex.
Model 2: additionally adjusted for number of chronic diseases, BMI (kg/m2),
education (low/intermediate/high), alcohol consumption (non/light/mod-
erate/excessive), smoking status (never/former/current), physical activity
(min/day), diabetes (yes/no), hypertension (yes/no), vitamin D (nmol/l) and
eGFR (ml/min/1.73m2).
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Development (OECD) questionnaire and validated by Statistics
Netherlands. Participants were asked whether they have difficulty
performing 7 common daily activities: 1) walk up and down a 15-step
staircase without resting, 2) dress and undress oneself, 3) sit down and
get up from a chair, 4) cut their own toenails, 5) walk 5min outside
without resting, 6) drive or use public transport 7) take a bath/shower.
The total score ranged from no limitation to limitations for all functions
(stairs/transport/toenails/dress/chair/walk/shower) score 0–7.
Functional performance was assessed with 3 objective functioning
tests. For the walk test, the participants were asked to walk 3m, turn
180°, and walk back 3m. For the chair-stand test participants were
asked to fold their arms across their chest and stand up from a sitting
position and sit down 5 times. The cardigan test measures upper ex-
tremity function. The participants were asked to put on and take off a
cardigan. The scores of the tests for all follow-up measurements were
based on quartiles of the time required at baseline. Participants unable
to perform the test scored 0. By summing up the scores of the individual
performance tests, the total physical performance score ranges from low
to high physical performance (0–12).
2.4. Baseline covariates
LASA interviewers obtained comprehensive data on participants’
demographics, anthropometrics and co-morbid conditions. Height was
measured to the nearest 0.1 cm using a stadiometer. Weight was mea-
sured without clothes and shoes to the nearest 0.1 kg using a calibrated
bathroom scale. Corrections have been made to adjust measured weight
for clothing (−2 kg) or a corset (−1 kg). Body mass index (BMI) was
calculated by dividing body weight by height squared (kg/m2).
A self-administered questionnaire was used to assess participants’
education level, smoking status, alcohol use and physical activity level.
Education was reported on a 9-category scale. We distinguished edu-
cation into 3 categories: low (elementary school or less), medium
(lower vocational or general intermediate education) and high (inter-
mediate vocational education, general secondary school, higher voca-
tional education, college or university). Smoking status was categorized
as never, former and current smoker. Alcohol use was based on the
number of days and amount of alcohol used characterized into 3 cate-
gories: none/light (0–3 glasses/week), moderate (4–7 glasses/week),
excessive or very excessive (≥8 glasses/week) according to the
Garretsen index.
Fig. 2. Mean values of (A) handgrip strength
(B) ≥1 functional limitation (C) calf cir-
cumference by dp-ucMGP tertiles.
Low dp-ucMGP solid line, medium dp-ucMGP
dotted line, high dp-ucMGP dashed line.
Data are presented as means (handgrip
strength/calf circumference N=633) or cross-
sectional percentages (≥1 functional limita-
tion, N= 540) adjusted for time (years), age
(years), sex, number of chronic diseases, BMI
(kg/m2), education (low/intermediate/high),
alcohol consumption (non/light/moderate/ex-
cessive), smoking status (never/former/cur-
rent), physical activity (min/day), diabetes (yes/no), hypertension (yes/no), vitamin D (nmol/L) and eGFR (ml/min/1.73m2)
Fig. 3. Sex-stratified mean values of physical
performance score by dp-ucMGP tertiles.
Low dp-ucMGP solid line, medium dp-ucMGP
dotted line, high dp-ucMGP dashed line
(N=286 men, N=332 women).
Data are presented as means adjusted for time
(years), age (years), number of chronic dis-
eases, BMI (kg/m2), education (low/inter-
mediate/high), alcohol consumption (non/
light/moderate/excessive), smoking status
(never/former/current), physical activity
(min/day), diabetes (yes/no), hypertension
(yes/no), vitamin D (nmol/L) and eGFR (ml/
min/1.73m2)
Table 3
Longitudinal associations between baseline plasma dp-ucMGP tertiles and
functional performance over 13 years follow-up.
Physical performance (0–12)
Men N=286 Women N=332
Model 1 Model 2 Model 1 Model 2
dp-ucMGP tertiles (pmol/L)

















P-trend 0.601 0.701 < 0.001 0.002
P-time < 0.001 <0.001 <0.001 <0.001
Note: Values are regression coefficients and 95% confidence intervals analyzed
with generalized estimating equations.
dp-ucMGP: dephosphorylated uncarboxylated matrix gla protein.
Model 1: adjusted for time (years) and age (years).
Model 2: additionally adjusted for number of chronic diseases, BMI (kg/m2),
education (low/intermediate/high), alcohol consumption (non/light/mod-
erate/excessive), smoking status (never/former/current), physical activity
(min/day), diabetes (yes/no), hypertension (yes/no), vitamin D (nmol/l) and
eGFR (ml/min/1.73 m2).
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The number of chronic diseases was based on self-report of the most
frequent somatic chronic diseases in the Netherlands. Physical activity
was assessed using the validated LASA physical activity questionnaire
in minutes per day by multiplying the frequency and duration of each
activity in the previous 2 weeks, and summing these values across ac-
tivities [19].
Furthermore, we estimated glomerular filtrate rate from serum
creatinine using the Chronic Kidney Disease Epidemiology
Collaboration 2009 equation, as indicator of kidney function. For vi-
tamin D status, serum 25(OH)D concentrations were determined using
a radioimmunoassay (DiaSorin, Stillwater, Minnesota, USA). The inter-
assay coefficient of variation was 10.0%. All biochemical analyses were
carried out by the Endocrine Laboratory of the VU University Medical
Center Amsterdam [19].
2.5. Statistical analysis
We divided dp-ucMGP concentrations into tertiles with the first
tertile as reference for all analyses indicating high vitamin K status as
no validated cut-off values for dp-ucMGP are established yet. Baseline
characteristics stratified by plasma dp-ucMGP concentrations were re-
ported as mean and standard deviation for normally distributed vari-
ables and skewed variables were reported as median and interquartile
range. Categorical variables are presented as number and percentage.
Functional limitations were dichotomized into ≥1 functional lim-
itation vs. no limitation as the reference group. Physical performance
was used as a continuous variable.
To determine the longitudinal relationship between the dp-ucMGP
tertiles and physical functioning, we used a generalized estimating
equation analysis to estimate regression coefficients or in case of
functional limitations odds ratios (OR) with 95% confidence intervals
from the WALD-test adjusting for potential confounders. We used an
exchangeable correlation structure because of the close correlation
between follow-up examination within participants [22].
A minimally adjusted model included dp-ucMGP, adjusted for
follow-up time (years) and baseline age and sex (model 1). Model 2
additionally included baseline number of chronic diseases, BMI (kg/
m2), education (low/intermediate/high), alcohol consumption (non/
light/moderate/excessive), smoking status (never/former/current),
physical activity (min/day), depression (CES-D 0–6), type 2 diabetes
(yes/no), hypertension (yes/no), vitamin D (nmol/L) and estimate
glomerular filtration rate (ml/min/1.73m2).
Sex was tested as potential effect modifier because of previously
observed sex differences for vitamin K supplementation and insulin by
including an interaction term (dp-ucMGP*sex) in both unadjusted and
adjusted models [23]. In case of significant effect modification
(P < 0.10), stratified analyses were performed.
To measure the rate of decline in physical functioning by dp-ucMGP
tertiles, an interaction term dp-ucMGP*time was added to the model. P-
for-trend was calculated over the dp-ucMGP tertiles using dp-ucMGP
tertiles as continuous exposure. We performed data analysis using SPSS
Statistics 23.0 with 2-sided P-values of 0.05.
3. Results
3.1. Study population
Of the 633 participants, the mean age was 59.9 ± 2.9 years and
54% (n= 342) were women. Mean BMI was 27.3 ± 4.2 kg/m2, 26%
were current smokers and 43% had a lower education level.
During a mean follow-up of 11.1 years (range 3–13), 432 partici-
pants completed all four subsequent examinations, 81 participants
completed three, 64 participants completed two, and 56 participants
completed one follow-up examination (Fig. 1).
3.2. Dp-ucMGP concentrations
Plasma dp-ucMGP was slightly skewed to the right with mean
concentrations of 376 ± 233 pmol/L. Plasma dp-ucMGP was divided
into tertiles: low:< 272 pmol/L, medium: 274–415 pmol/L and high
≥416 pmol/L dp-ucMGP (Table 1). Participants in the highest dp-
ucMGP tertile were slightly older, more often women, more likely to
have a higher BMI, and had more chronic diseases.
3.3. Longitudinal associations physical functioning
All groups declined in handgrip strength over time (P-time<
0.001), but participants in the lowest dp-ucMGP tertile had the greatest
handgrip strength (Table 2/Fig. 2). After adjusting for confounders, the
medium and highest tertile were associated with lower handgrip
strength: regression coefficient −1.0 kg (95% confidence interval
−1.9, 0.0) and −1.1 kg (−2.1, −0.1) respectively, P-trend= 0.022.
The relationship between dp-ucMGP tertiles was positively asso-
ciated with greater calf circumference in model 1, but showed a re-
versed trend in the fully adjusted model: −0.3 (−0.6, 0.1) and −0.5
(−0.9, −0.1), P-trend=0.018 for the medium and highest dp-ucMGP
tertiles, respectively.
For the relationship between dp-ucMGP tertiles and functional
limitation, we observed a gradual increase in the unadjusted percentage
of ≥1 functional limitations (P-time< 0.001). In the fully adjusted
model, the relationship between dp-ucMGP tertiles attenuated and was
no longer significant: OR 1.0 (0.6–1.6) and 1.3 (0.8–2.2) for the
medium and high dp-ucMGP tertiles, respectively. No significant in-
teraction was observed by sex in the relationship between dp-ucMGP
tertiles with handgrip strength, calf circumference and ≥1 functional
limitation (P-interaction>0.165). In none of the models, the interac-
tion dp-ucMGP*time with handgrip strength, calf circumference and
≥1 functional limitation was significant (P-decline> 0.208), in-
dicating no difference in decline of physical functioning by dp-ucMGP
tertiles.
Sex was a significant effect modifier in the relationship between dp-
ucMGP and physical performance (P-interaction<0.001). Both men
and women, decreased in physical performance over time (P-time<
0.001) (Fig. 3). For women, higher dp-ucMGP concentrations were
associated with lower physical performance scores in the fully adjusted
model: medium tertile −0.6 (−1.0, −0.2), high tertile −0.7 (−1.1,
−0.3), P-trend=0.002 (Table 3), but the interaction term for decline
was not significant (P-decline= 0.812). No statistically significant as-
sociations were observed between dp-ucMGP and physical performance
in men.
4. Discussion
We examined whether vitamin K status, measured by plasma dp-
ucMGP, was associated with physical functioning over a period of 13
years. Our findings show that higher dp-ucMGP concentrations, in-
dicating a lower vitamin K status, were associated with lower handgrip
strength and calf circumference. In the relationship between dp-ucMGP
with physical performance, effect modification was present. In women,
not in men, higher dp-ucMGP was related to lower physical perfor-
mance scores. The rate of decline was not significantly different by dp-
ucMGP tertiles for any physical functioning measure.
Our findings suggest that higher dp-ucMGP is associated with lower
handgrip strength, calf circumference, and with better physical per-
formance in women. Particularly, handgrip strength is an essential
component of physical functioning [20]. We observed meaningful dif-
ferences in physical performance scores in women (low vs. high dp-
ucMGP tertile−0.7 (−1.1, −0.3) since a clinical meaningful change in
physical performance score is between 0.4-1.5 points on a 12-point
scale [24]. Overall, our results suggest that optimal vitamin K con-
centrations are an important determinant for physical functioning in
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old age.
Our study is the first that investigated vitamin K status in relation
with physical functioning over long-term follow-up in older adults. In
the Health-ABC study, both phylloquinone and dp-ucMGP were asso-
ciated with better functional performance (using short physical per-
formance battery) scores) and greater 20m gait speed, however, the
results attenuated after 4–5 years follow-up and none of the vitamin K
status measures were associated with decline in walking speed or
functional performance [13]. Up to now, only one randomized con-
trolled trial has been conducted of vitamin K supplementation using
physical functioning as an outcome. A daily dose of 100 μg of vitamin
K2 versus placebo for 6 months did not improve handgrip strength and
the short physical performance battery in participants ≤70 years with
established vascular disease [25]. It should be noted that these physical
function measures were secondary outcomes of the trial.
Our findings indicate that dp-ucMGP was not associated with phy-
sical functioning when measured with performance tests in men. To our
knowledge, no other study observed effect modification for sex between
vitamin K status and physical performance. Previous studies indicate
that the function and absorption of vitamin K is not sex specific [26],
however, vitamin K supplementation only reduced progression of in-
sulin resistance in men [23]. Hormonal differences may act differently
for physical functioning measures and might be an explanation for our
observed interaction effect. Another explanation might be sex-differ-
ences in body composition. Lower vitamin K status is associated with
increased body fat in older adults, which is more evident in women
[27]. Also, lifestyle factors might play a role in the relationship between
vitamin K status and physical functioning. In our study, more men were
excessive alcohol drinkers; 19% vs. 3%), smokers (31% vs. 21%) and
were less physically active (228min/day vs. 336min/day; P < 0.001),
compared to women. It is plausible that a high vitamin K status reflects
a healthy diet and lifestyle, as the primary source of vitamin K are
characteristics of a healthy diet.
4.1. Strength and limitations
The strengths of this study include the comprehensive phenotyping
and long-term follow-up with 68% of the sample attending all follow-up
examinations. We used a comprehensive set of physical functioning
measures assessed in a standardized way minimalizing potential bias
and misclassification. This contributes to an extensive understanding of
the role of vitamin K in physical function, which is related to daily
functioning. Moreover, we used plasma dp-ucMGP as a marker of vi-
tamin K status. Previous research has shown that plasma dp-ucMGP is a
reliable marker to determine overall vitamin K status [7]. In addition,
plasma dp-ucMGP has advantages over plasma phylloquinone (vitamin
K1), which only reflects recent intake, and plasma menaquinone (vi-
tamin K2), which is often below detection limit in the general popula-
tion [3].
This study also has some limitations. The excluded participants were
older, had more often chronic diseases, were more current smokers,
excessive alcohol drinkers, and therefore, the observed associations in a
relatively healthier group might have been underestimated. In addition,
dp-ucMGP is only measured at baseline, and it is unknown if vitamin K
intake would be stable over 13 years follow-up. Since multiple me-
chanisms are involved in physical functioning, future studies would
benefit from measuring multiple vitamin K status markers to dis-
criminate between different mechanisms including the total amount of
MGP. Also, no nutritional information was available. It is possible that
participants with a low vitamin K status also have other nutritional
deficiencies that potentially influence physical functioning [28].
4.2. Public health implications
Our findings implicate that dp-ucMGP may be associated with
physical functioning, which may have important public health
implications. A sufficient vitamin K status can be obtained with a ba-
lanced diet, which includes vitamin K rich foods such as green leafy
vegetables, animal and fermented dairy products such as meat, eggs,
yoghurt and cheese. The adequate intake by the European Food Safety
Authority panel is set on 1 μg vitamin K1 per kg body weight per day
[29], however adequate controlled feeding trials are needed to accu-
rately determine the amount of vitamin K that is required to achieve
any level of vitamin K status. Future studies are needed to determine
whether vitamin K rich foods or vitamin K supplementation could im-
prove physical functioning in those with vitamin K insufficiency and
clarify underlying mechanisms.
5. Conclusion
A low vitamin K status was associated with lower handgrip strength,
smaller calf circumference and in women a low vitamin K status was
related to poorer physical performance. A low vitamin K status was
however not related to the 13 year decline in these measures.
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